Management of Long-Term Complications of HIV Disease: Focus on Cardiovascular Disease

HIV-infected individuals on effective antiretroviral therapy experience a number of non-AIDS noncommunicable diseases, such as cardiovascular disease, more frequently than uninfected individuals. Common pathways for such diseases are chronic immune activation and inflammation, including the prolonged inflammation associated with lower nadir CD4+ cell count. Prevention and treatment of non-AIDS conditions include treatment of traditional risk factors, lifestyle interventions, earlier initiation of antiretroviral therapy, and potentially therapies specifically targeting inflammation and im mune activation (eg, statins). This article summarizes a presentation by Judith S. Currier, MD, at the IAS–USA continuing education program, Improving the Management of HIV Disease, held in New York, New York, in February 2017